Rize Oncology Inc.
Rize Oncology Inc.
CSE Index:
CSE CompositeCurrency:
CAD Rize Oncology Inc. is a pharmaceutical company dedicated to developing innovative oncology therapies. With a focus on advancing treatments for soft tissue sarcoma, Rize Oncology aims to make a meaningful impact on patients' lives by Turning the Tide on Metastasis.
Rize Oncology Inc. (RIZE)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
CanadaPhone
(514) 796-2640Email
Roland@genetether.comWebsite
https://www.rizeoncology.comListing date
Monday, March 28, 2022Transfer Agent
Odyssey Trust CompanySEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
CanadaPhone
(514) 796-2640Email
Roland@genetether.comWebsite
https://www.rizeoncology.comListing date
Monday, March 28, 2022Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
75744674Reserved for Issuance:
17942855Company Officers
Roland Boivin, Chief Executive Officer
Daren Graham, Chairman
James O'Neill, Chief Financial Officer
John Rothman, Chief Scientific Officer
Bulletins
10/01/2025
2025-0106– Name and Symbol Change - GeneTether Therapeutics Inc. (GTTX)
le 10 janvier/January 2025
GeneTether Therapeutics Inc. (GTTX) has announced a name and symbol change to Rize Oncology Inc. (RIZE)
Shares will begin trading under the new name and symbol and with a new CUSIP number on January 13, 2025.
Disclosure documents are available at www.thecse.com.
